A Pharmacokinetic, Safety, and Tolerability Trial of Palovarotene in Healthy Japanese and Non-Japanese Participants.
Louise DubeNobuhiko HagaDonna GroganJulien OgierKim-Hanh Le Quan Sang
Published in: European journal of drug metabolism and pharmacokinetics (2023)
Japanese and non-Japanese groups had similar pharmacokinetic profiles, indicating that palovarotene dose adjustments are not necessary for Japanese patients with FOP.